
BriaCell Therapeutics Corp.
BCTXHealthcare|Biotechnology|CA
$3.95
+0.68 (+20.80%)
DCF Value
$0.59
Tangible Book / Share
$1.77
Cash / Share
$2.36
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 2, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Dec 2027
Est. completion
P3Breast Cancer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT06072612n=404
Recent Press Releases
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
Nov 6, 2026 · GlobeNewsWire
BriaCell Awarded 2026 “Immunotherapy Solution of the Year” By BioTech Breakthrough
Nov 5, 2026 · GlobeNewsWire
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
Nov 3, 2026 · GlobeNewsWire
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Oct 23, 2026 · GlobeNewsWire
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Oct 6, 2026 · GlobeNewsWire
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study
Sep 14, 2026 · GlobeNewsWire
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
Sep 8, 2026 · GlobeNewsWire
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
Aug 24, 2026 · GlobeNewsWire
SEC Filings (77)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 28, 2026 | 10-K | Annual report | DocumentIndex |
| Jun 26, 2026 | 8-K | Material event | DocumentIndex |
| Jun 9, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| Jun 2, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 10, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Mar 9, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | 25-NSE | DocumentIndex | |
| Feb 20, 2026 | 8-K | Material event | DocumentIndex |
| Feb 12, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jan 23, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 15, 2026 | 8-K | Material event | DocumentIndex |
| Jan 14, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Jan 13, 2026 | EFFECT | DocumentIndex | |
| Jan 13, 2026 | S-1MEF | IPO / offering registration | DocumentIndex |
| Jan 13, 2026 | CERT | DocumentIndex | |
| Jan 13, 2026 | 8-A12B | DocumentIndex | |
| Dec 29, 2025 | 8-K | Material event | DocumentIndex |
| Dec 23, 2025 | FWP | DocumentIndex | |
| Dec 23, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Dec 11, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Dec 1, 2025 | 8-K | Material event | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 16, 2025 | 10-K | Annual report | DocumentIndex |
| Oct 10, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 26, 2025 | 8-K | Material event | DocumentIndex |
| Aug 1, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Jul 28, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 22, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 21, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 16, 2025 | 8-K | Material event | DocumentIndex |
| Jul 16, 2025 | 424B4 | Offering prospectus | DocumentIndex |
| Jul 15, 2025 | EFFECT | DocumentIndex | |
| Jul 11, 2025 | FWP | DocumentIndex | |
| Jul 10, 2025 | S-1/A | IPO / offering registration | DocumentIndex |
| Jul 9, 2025 | S-1/A | IPO / offering registration | DocumentIndex |
| Jul 8, 2025 | FWP | DocumentIndex | |
| Jul 8, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Jun 18, 2025 | 8-K | Material event | DocumentIndex |